ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 65 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $205,000 | +19.2% | 22,300 | 0.0% | 0.00% | – |
| Q4 2016 | $172,000 | -32.5% | 22,300 | 0.0% | 0.00% | – |
| Q3 2016 | $255,000 | +22.6% | 22,300 | +32.0% | 0.00% | – |
| Q2 2016 | $208,000 | -19.1% | 16,900 | +48.2% | 0.00% | – |
| Q4 2015 | $257,000 | +21.2% | 11,400 | -10.9% | 0.00% | – |
| Q3 2015 | $212,000 | -26.4% | 12,800 | 0.0% | 0.00% | – |
| Q2 2015 | $288,000 | +25.8% | 12,800 | +43.8% | 0.00% | – |
| Q1 2015 | $229,000 | +102.7% | 8,900 | +71.2% | 0.00% | – |
| Q4 2014 | $113,000 | -9.6% | 5,200 | -21.2% | 0.00% | – |
| Q3 2014 | $125,000 | -17.2% | 6,600 | +1.5% | 0.00% | – |
| Q2 2014 | $151,000 | +202.0% | 6,500 | +341.3% | 0.00% | – |
| Q1 2014 | $50,000 | +2400.0% | 1,473 | +1917.8% | 0.00% | – |
| Q4 2013 | $2,000 | +100.0% | 73 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,400,289 | $14,653,000 | 2.28% |
| ADAMS STREET PARTNERS LLC | 1,839,730 | $6,126,000 | 1.44% |
| Iguana Healthcare Management, LLC | 400,000 | $1,332,000 | 0.75% |
| ELEMENT CAPITAL MANAGEMENT LLC | 91,059 | $303,000 | 0.06% |
| TURNER INVESTMENTS LLC | 24,783 | $83,000 | 0.06% |
| Birchview Capital, LP | 28,689 | $96,000 | 0.05% |
| Cannell & Co. | 407,741 | $1,358,000 | 0.05% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $160,000 | 0.03% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 329,100 | $1,096,000 | 0.02% |
| Burt Wealth Advisors | 7,519 | $25,000 | 0.02% |